We tested the D-galactosamine sensitization model with staphylococcal enterotoxin B (SEB). LPS was required for the lethal effects of SEB in D-galactosamine sensitized mice. Only two (2/62) among the C3HeB/FeJ (H-2k), Balb/c (H-2d) and C57BL/6J (H-2b) mice died in response to SEB in the absence of LPS whereas injection of SEB and minimally lethal concentrations of LPS became highly toxic. Similar to LPS, the lethal effect of SEB was dependent on the mouse strain used. Mouse strains more sensitive to the effects of LPS (Balb/c and C57BL/6J) were also more sensitive to the effects of SEB in comparison to C3H mice when equivalent doses of LPS and SEB were used. Among Balb/c and C3HeB/FeJ but not C57BL/6J mice, SEB (20 μg) potentiated the lethal effects of LPS at low doses (0.1 μg LPS), but had an apparent protective effect at high doses (1 μg LPS). Lastly, there was an inverse correlation between pathogenesis and serum IL-2 concentrations and splenic T cell activation in C3H mice. However, macrophage mobilization did correlate with lethality. Therefore, some questions remain about the mechanisms involved in the D-galactosamine/SEB pathogenesis model. We conclude that when sensitizing mice with D-galactosamine and assessing the lethal effects of SEB, endotoxin contamination must be assessed.
Get full access to this article
View all access options for this article.
References
1.
Tracey K., Cerami A.Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol1993; 9: 317-343.
2.
Dinarello C.Biology of interleukin 1. FASEB J1988; 1: 108-115.
3.
Tracey K., Fong Y., Hesse D. et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature1987; 330: 662-664.
4.
Raponi G., Keller N., Rozenberg-Arska M., Lun M., Mancini C., Verheof J.Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity. Infect Immun1993; 61: 3976-3980.
5.
Boujoukos A. , Martich G., Supinski E., Suffredini A.Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. J Appl Physiol1993; 74: 3027-3033.
6.
Molloy R., Mannick J., Rodrick M.Cytokines, sepsis and immunomodulation. Br J Surg1993; 80: 289-297.
7.
Kohler J., Heumann D., Garotta G. et al. IFN-gamma involvement in the severity of gram-negative infections in mice. J Immunol1993; 151: 916-921.
8.
Van Der Poll T., Sauerwein H.Tumour necrosis factor-alpha: its role in the metabolic response to sepsis. Clin Sci1993; 84: 247-256.
9.
Brouckaert P. , Everaerdt B., Fiers W.The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor. Eur J Immunol1992; 22: 981-986.
10.
Gonzalo JA, Baixeras E., Gonzalez-Garcia A. et al. Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. J Immunol1994; 152: 1597-1608.
11.
Beutler B., Krochin N., Milsark I., Luedke C., Cerami A.Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science1986; 232: 977-980.
12.
Gonzalo J., Gonzalez-Garcia A., Martinez AC, Kroemer G.Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J Exp Med1993; 177: 1239-1246.
13.
Freudenberg M., Keppler D., Galanos C.Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun1986; 51: 891-895.
14.
Matsuo R., Ukida M., Nishikawa Y., Omori N., Tsuji T.The role of Kuppfer cells in complement activation in D-galactosamine/lipopolysaccharide-induced hepatic injury of rats. Acta Med Okayama1992 ; 46: 345-354.
15.
Okabe H., Irita K., Kurosawa K. et al. Increase in the plasma concentration of reduced glutathione observed in rats with liver damage induced by lipopolysaccharide/D-galactosamine: effects of ulinastatin, a urinary trypsin inhibitor. Circ Shock1993; 41: 268-272.
16.
Zhang P., Xie M., Spitzer J.Hepatic neutrophil sequestration in early sepsis: enhanced expression of adhesion molecules and phagocytic activity. Shock1994 ; 2: 133-140.
17.
Lehmann V., Freudenberg M., Galanos C.Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med1987; 165: 657-663.
18.
Herman A., Kappler J., Marrack P., Pullen A.Superantigens: mechanism of T-cell stimulation and role in immune responses . Annu Rev Immunol1991; 9: 745-772.
19.
Grossman D. , Lamphear J., Mollick J., Betley M., Rich R.Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect Immun1992; 60: 5190-5196.
20.
Taub D., Blank K.Superantigens and microbial pathogenesis. Ann Intern Med1993; 119: 89-90.
21.
Jackett S., Stevens D.Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. J Infect Dis1993; 168: 232-235.
22.
Marrack P., Blackman M., Kushnir E., Kappler J.The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells . J Exp Med1990; 171: 455-464.
23.
Chapes S., Mastro A., Sonnenfeld G., Berry W.Antiorthostatic suspension as a model for the effects of spaceflight on the immune system. J Leukoc Biol1993; 54: 227-235.
24.
Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P., Wagner H.T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med1992; 175: 91-98.
25.
Nagaki M., Muto Y., Ohnishi H. et al. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology1994; 106: 450-458.
26.
Miethke T., Wahl C., Regele D., Gaus H., Heeg K., Wagner H.Superantigen mediated shock: a cytokine release syndrome. Immunobiology1993; 189: 270-284.
27.
Uchiyama T. , Yan X., Imanishi K., Yagi J.Bacterial superantigens - mechanisms of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol Immunol1994 ; 38: 245-256.
Chapes S., Beharka A., Hart M., Smeltzer M., landolo J.Differential RNA regulation by staphylococcal enterotoxins A and B in murine macrophages. J Leukoc Biol1994; 55: 523-529.
30.
Beharka A., Armstrong J., landolo J., Chapes S.Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins. Infect Immun1994; 62: 3907-3915.
31.
Beharka A., landolo J., Chapes S.Staphylococcal enterotoxins bind H-2Db molecules on macrophages . Proc Natl Acad Sci USA1995; In press.
32.
Chapes S., Hoynowski S., Woods K., Armstrong J., Beharka A., landolo J.Staphylococcus-mediated T cell activation and spontaneous natural killer cell activity in the absence of major histocompatibility complex class II molecules . Infect Immun1993; 61: 4013-4016.
33.
Fleming S., Rosenkrans C., Chapes S.Test of the antiorthostatic suspension model on mice: effects on the inflammatory cell response. Aviat Space Environ Med1990 ; 61: 327-332.
34.
Kopydlowski K., McVey D., Woods K., landolo J., Chapes S.Effects of antiorthostatic suspension and corticosterone on macrophage and spleen cell function. J Leukoc Biol1992; 52: 202-208.
Miethke T., Gaus H., Wahl C., Heeg K., Wagner H.T-Cell-dependent shock induced by a bacterial superantigen. In: Fleischer B. (ed). Biological Significance of Superantigens. Basel: Karger , 1992: 172-184.
37.
Watson J., Largen M., McAdam K.Genetic control of endotoxic responses in mice. J Exp Med1978; 147: 39-49.
38.
Vogel S., Hansen C., Rosenstreich D.Characterization of a congenitally LPS-resistant, athymic mouse strain. J Immunol1979; 122: 619-622.
39.
Ochiya T., Baba T., Mizushima A., Onozaki K., Yaoita H.Induction of macrophage disappearance reaction by immunoadsorbed MIF. Cell Immunol1982; 71: 346-352.
40.
Barth M., Hendrzak J., Melnicoff M., Morahan P.Review of the disappearance reaction. J Leukoc Biol1995; 57: 361-367.
41.
See R., Kum W., Chang A., Goh S., Chow A.Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes. Infect Immun1992; 60: 2612-2618.
42.
Stiles B., Bavari S., Krakauer T., Ulrich R.Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecules dependency and cytokine release. Infect Immun1993; 61: 5333-5338.
43.
Hogan M., Vogel S.Inhibition of macrophage tumoricidal activity by glucocorticoids. J Immunol1988; 140: 513-519.
44.
Zuckerman S. , Shellhaas J., Butler L.Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: Effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol1989; 19: 301-305.
45.
Silverstein R., Turley B., Christoffersen C., Johnson D., Morrison D.Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary. J Exp Med1991; 173: 357-365.
46.
Toft P., Lillevang S., Tonnesen E., Svendsen P., Kohndorf K.Redistribution of lymphocytes following E. coli sepsis. Scand J Immunol1993; 38: 541-545.
47.
Nagakawa J. , Hishinuma I., Hirota K. et al. Protective effects of E3330, a novel quinone derivative, on galactosamine/tumor necrosis factor-induced hepatitis in mice. Eur J Pharmacol1992; 229: 63-67.
48.
Kusher D., Ware C., Gooding L.Induction of the heat shock response protects cells from lysis by tumor necrosis factor. J Immunol1990; 145: 2925-2931.
49.
Sugawara S. , Nowicki M., Xie S., Song H-J., Dennert G.Effects of stress on lysability of tumor targets by cytotoxic T cells and tumor necrosis factor. J Immunol1990; 145: 1991-1998.
50.
Jaattela M. , Wissing D., Bauer P., Li G.Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J1992; 11: 3507-3512.
51.
Jaattela M., Wissing D.Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection. J Exp Med1993; 177: 231-236.
52.
Jaattela M.Overexpression of major heat shock protein hsp70 inhibits tumor necrosis factor-induced activation of phospholipase A2. J Immunol1993; 151: 4286-4294.
53.
Snyder Y., Guthrie L., Evans G., Zuckerman S.Transcriptional inhibition of endotoxin-induced monokine synthesis following heat shock in murine peritoneal macrophages. J Leukoc Biol1992; 51: 181-187.
54.
Fouqueray B. , Philippe C. Amrani A, Perez J., Baud L.Heat shock prevents lipopolysaccharide-induced tumor necrosis factor synthesis by rat mononuclear phagocytes. Eur J Immunol1992; 22: 2983-2987.
55.
Bean A., Freiberg R., Andrade S., Menon S., Zlotnik A.Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immun1993; 61: 4937-4939.
56.
Florquin S. , Amraoui Z., Abramowicz D., Goldman M.Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol1994; 153: 2618-2623.
57.
LeClaire R. , Kell W., Sadik R., Downs M. Parker G.Regulation of staphylococcal enterotoxin B-elicited nitric oxide production by endothelial cells. Infect Immun1995; 63: 539-546.
58.
Gonzalo J., Gonzalez-Garcia A., Baixeras E. et al. Pertussis toxin interferes with superantigen-induced deletion of peripheral T cells without affecting T cell activation in vivo. J Immunol1994; 152: 4291-4299.
59.
Harris T., Grossman D., Kappler J., Marrack P., Rich R., Betley M.Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun1993; 61: 3175-3183.
60.
Grusby M., Johnson R., Papaioannou V., Glimcher L.Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science1991; 253: 1417-1420.
61.
Hino Y., Kumashiro R., Tanaka M. et al. Involvement of activated polymorphonuclear leukocytes in galactosamine-induced hepatic injury in rats. J Clin Biochem Nutrit1994; 16: 27-36.
62.
Xu H., Gonzalo J., St Piere Y et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med1994; 180: 95-109.
63.
Armstrong J. , Simske S., Beharka A., Balch S., Luttges M., Chapes S.Class I and class II major histocompatibility (MHC) molecules play a role in bone marrow-derived macrophage development . J Leukoc Biol1994; 55: 658-661.
